Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections

INTRODUCTION: The effects of the GLP-1 analogue liraglutide on time in hypoglycaemia, time in hyperglycaemia, and time in range for type 2 diabetes patients initially treated with multiple daily insulin injections (MDI) were investigated. Variables associated with hypoglycaemia in the current popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Sofizadeh, Sheyda, Imberg, Henrik, Ólafsdóttir, Arndís F., Ekelund, Magnus, Dahlqvist, Sofia, Hirsch, Irl, Filipsson, Karin, Ahrén, Bo, Sjöberg, Stefan, Tuomilehto, Jaako, Lind, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848584/
https://www.ncbi.nlm.nih.gov/pubmed/31564026
http://dx.doi.org/10.1007/s13300-019-00692-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848584/
https://www.ncbi.nlm.nih.gov/pubmed/31564026
http://dx.doi.org/10.1007/s13300-019-00692-1

Ejemplares similares